Our proven, cohesive leadership team is comprised of innovative and dedicated drug developers, scientists, clinicians, and business leaders.
Co-Founder & CEO
William Haskins
Dr. Haskins brings 20+ years experience in therapeutic R&D, including leadership roles at Genentech and Catalent. Well-versed in CNS biomarkers and large molecule drug development (OCREVUS®, KADCYLA®, POLIVY®, etc.).
Co-Founder & CTO
Franklin Okumu
Dr. Okumu brings 20+ years in R&D experience from Genentech, Novo Nordisk, and Dr. Reddy's (KADCYLA®, PERJETA®, DIFICID®, SERNIVO®, ZEMBRACESYMTOUCH®, IMPOYZ®, etc.)
Dr. Lowman brings 20+ years of leadership roles in antibody engineering at Genentech, NGM Biopharmaceuticals, CytomX Therapeutics, Triphase Accelerator U.S.
Co-Founder & Clinical Advisor
Todd Kilbaugh
Dr. Kilbaugh is the Associate Anesthesiologist in Chief and Associate Chair of Research for the Department of Anesthesiology and Critical Care Medicine at the Children’s Hospital of Philadelphia.